Not at all. Simply stated facts comparing the 2 very different companies. Bucilamine may be a good thing. May not. But, they need to find a use beyond COVID 19 because the window on that is pretty short, 5 years max, likely less. But, right now they only have hope, which doesn’t pay the bills. Should have a better idea after the New Year. Until then, nothing to do really but watch the company print paper with every ineffective news blurb and read the posts of the same 3, or fewer, posters. Sad but true.